• Experts
  • Supporters
  • About Mirrors of Medicine
Home
  • Disease Area
    • Bladder cancer
    • Breast cancer
    • Chronic pain
    • COVID-19
    • Lower Urinary Tract Dysfunction
    • Prostate cancer
    • Prostate cancer (US version)
    • Renal Cell Carcinoma
  • Method
  • Accreditation
  • my dashboard
  • Join
  • Login
  • EN
    EN FR DE IT ES RU UK
  • Bladder cancer
  • Breast cancer
  • Chronic pain
  • COVID-19
  • Lower Urinary Tract Dysfunction
  • Prostate cancer
  • Prostate cancer (US version)
  • Renal Cell Carcinoma
  • Method
  • Accreditation
  • Method
  • Experts
  • Supporters
  • Principles
  • About Mirrors of Medicine
  • Contact

Renal Cell Carcinoma

First-line systemic therapy in mRCC

  • Editor in chief
  • Experts & associates
  • Background & relevance
  • Last update: 24-08-2022

View the PinPoint cases (
) and get feedback

Progressive disease after nephrectomy (1)
Progressive disease after nephrectomy (2)
De novo metastatic ccRCC (2)
De novo metastatic ccRCC (1)
Progressive disease after nephrectomy (4)
Progressive disease after nephrectomy (5)
Progressive disease after nephrectomy (3)
De novo metastatic pRCC

Do the QuickScan and see where you are in comparison to your colleagues!

Continue with an accredited CME course and earn 1 ECMEC

Study 5 cases, answer 10 questions and earn 1 ECMEC

Feedback

Help us to improve the PPCP platform

Home
PinPoint Case Platform

Essential clinical questions addressed by short cases with targeted feedback

  • How we work
    • Method
    • Experts
    • Supporters
    • About Mirrors of Medicine
    • Newsletter
  • Disease areas
    • Bladder cancer
    • Breast cancer
    • Chronic pain
    • COVID-19
    • Lower Urinary Tract Dysfunction
    • Prostate cancer
    • Prostate cancer (US version)
    • Renal Cell Carcinoma
  • Contact
    • Contact us footer.contact_click_image info@mirrorsofmedicine.org
    • Privacy policy
    • Terms & Conditions

© Copyright 2023 Mirrors of Medicine